[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370000-105":59,"doc-detail-370000-en":123},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":116,"head_meta":118,"extra_data":120,"updated_unix":122},105,"en","risk-of-cancer-in-people-with-hiv-experiencing-varying-degrees-of-immune-recovery-with-sustained-virological-suppression-on-antiretroviral-treatment-for-more-than-2-years-an-international-multicenter-observational-cohort","Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years - An International, Multicenter, Observational Cohort","","Long-term virological suppression and immune (CD4) recovery have uncertain effects on non–AIDS-defining cancers in people living with HIV. An international, multicenter observational cohort assessed whether suboptimal immune recovery relates to incident cancer among participants with sustained virological suppression on antiretroviral therapy for at least 2 years. Higher time-updated CD4 counts were linked to a reduced overall cancer risk, independent of pre-ART nadir CD4, indicating poorer immune recovery increases cancer incidence.",{"@graph":69,"@context":115},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-of-cancer-in-people-with-hiv-experiencing-varying-degrees-of-immune-recovery-with-sustained-virological-suppression-on-antiretroviral-treatment-for-more-than-2-years-an-international-multicenter-observational-cohort/370000/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-of-cancer-in-people-with-hiv-experiencing-varying-degrees-of-immune-recovery-with-sustained-virological-suppression-on-antiretroviral-treatment-for-more-than-2-years-an-international-multicenter-observational-cohort/370000.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109],{"name":110,"@type":111,"acceptedAnswer":112},"What are the study’s practical implications for clinical care?","Question",{"text":113,"@type":114},"The findings support early HIV diagnosis and ART initiation, along with appropriate cancer screening strategies for people with poor immune recovery.","Answer","https://schema.org",{"og:url":83,"og:type":117,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":119,"canonical":83},"index,follow",{"doc_id":121,"site_id":62},370000,1791017800,{"code":4,"msg":5,"data":124},{"doc_id":121,"user_id":125,"nickname":92,"user_avatar":126,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":132,"language":133,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":67,"update_tm":137,"read_time":138,"preview_page_count":19,"preview_urls":139},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Clinical Infectious Diseases  \nMAJOR ARTICLE  \nRisk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort  \nWin Min Han,1, Lene Ryom,2,3,4 Caroline A. Sabin,5, Lauren Greenberg,2 Matthias Cavassini,6, Alexander Egle,7 Claudine Duvivier,8  \nFerdinand W. N. M. Wit,9,10, Cristina Mussini,11 Antonella d’Arminio Monforte,12 Antonella Castagna,13, Jose M. Miro,14,15, Marc van der Valk,9,10 Fabrice Bonnet,16, Christian Pradier,17, Matthias Skocic,7 Raimonda Matulionyte,18, Marcel Stöckle,19, Nadine Jaschinski,3 Alisa Timiryasova,3 Joan Tallada,20, Felipe P. Rogatto,21 Vani Vannappagari,22 Lital A. Young,23 Jens D. Lundgren,2,3, Kathy Petoumenos,1 and Jennifer F. Hoy24,a,; on behalf of the D:A:D and RESPOND Study Groups  \n1Kirby Institute, UNSW, Sydney, New South Wales, Australia; 2CHIP, Rigshospitalet, Copenhagen, Denmark; 3Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark; 4Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 5Institute for Global Health, University College London, London, United Kingdom; 6Department of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland; 73rd Medical University Department, Paracelsus Medical University, Salzburg, Austria; 8AP-HP Hôpital Necker-Enfants Malades, Université Paris Cité, Paris, France; 9Stichting HIV Monitoring Foundation, Amsterdam, The Netherlands; 10Department of Infectious Diseases, Amsterdam Institute for Immunology and Infectious Disease, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 11Department of Infectious Diseases, Università Degli Studi di Modena, Modena, Italy; 12Department of Health Sciences, ASST Santi Paolo e Carlo, Milano, Italy; 13San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy; 14Hospital Clinic-IDIBAPS, University of Barcelona and Reial Academia de Medicina de Catalunya, Barcelona, Spain; 15CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain; 16Service de Médicine Interne et Maladies, Infectieuses, CHU de Bordeaux and Bordeaux University, BPH, INSERM U1219, Bordeaux, France; 17Department of Public Health, Prevention and Health Promotion, Université Côte D’Azur et Centre Hospitalier Universitaire, Nice, France; 18Department of Infectious Diseases and Dermatovenerology, Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; 19Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, University of Basel, Basel, Switzerland; 20European AIDS Treatment Group, Brussels, Belgium; 21Gilead Sciences, Inc, Foster City, California, USA; 22ViiV Healthcare, Research Triangle Park, North Carolina, USA; 23Merck Sharp & Dohme, Rahway, New Jersey, USA; and 24Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia  \nBackground. The impact of long-term virological suppression (VS) and CD4 count recovery on non–AIDS-defining cancers (NADCs) is unclear. We determined whether poor immune recovery was associated with incident cancer risk in people with human immunodeficiency virus (HIV) with VS.  \nMethods. Participants from the Data-Collection on Adverse Effects of Anti-HIV Drugs (D:A:D) and International Cohort Consortium of Infectious Disease (RESPOND) collaborations in Europe and Australia who achieved ≥2 years of VS on antiretroviral therapy (ART) between December 1999 and December 2022 were included. Follow-up was from baseline (date of VS for 2 years) until the earliest of a first cancer event, virological failure, final follow-up, or administrative censoring date. Multivariable Poisson regression was used to assess associations between cancer incidence (overall, AIDS-defining cancer, NADC, inf","cbCaii6FFiG81ez6","https://ap.wps.com/l/cbCaii6FFiG81ez6","pdf",831257,14,"English","# Background\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What are the study’s practical implications for clinical care?\",\"answer\":\"The findings support early HIV diagnosis and ART initiation, along with appropriate cancer screening strategies for people with poor immune recovery.\"}]","Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years - An International, Multicenter, Observational Cohort | PDF",1790186206,35,[140,144,148,152],{"page_no":8,"url":141,"width":142,"height":143},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b96ddbde5861ce0b433787fea4b26e22.webp",983,1296,{"page_no":14,"url":145,"width":146,"height":147},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff5d9c11e10219e656e1bd599044813b.webp",982,1294,{"page_no":81,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d37caeb8ab7927168508bb37c401826.webp",981,1293,{"page_no":19,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2967f7cb2a4ce5e647bf58be74bb359e.webp",980,1292]